Crossmark

Differentiating clinically significant prostate cancer from clinically insignificant prostate cancer using qualitative and semi-quantitative indices of dynamic contrast-enhanced MRI

Crossref DOI link: https://doi.org/10.1007/s12672-024-01668-9

Published Online: 2024-12-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tamada, Tsutomu

Takeuchi, Mitsuru

Watanabe, Hiroyuki

Higaki, Atsushi

Moriya, Kazunori

Kanki, Akihiko

Fukukura, Yoshihiko

Yamamoto, Akira
License Information

Text and Data Mining valid from 2024-12-18

Version of Record valid from 2024-12-18
More Information

Article History

Received: 20 August 2024

Accepted: 3 December 2024

First Online: 18 December 2024

Declarations

:

: The authors declare no competing interests.

: This study was approved by the Ethics Committee of Kawasaki Medical School (Application No. 5490-02) and was performed in accordance with principles of the 1964 Helsinki Declaration and its later amendments. Informed consent was waived for this study because of its retrospective design.

Document is current

Any future updates will be listed below